Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by VentureGuy24on Oct 14, 2016 8:47am
203 Views
Post# 25342776

Great news! A commercial drug to market...

Great news! A commercial drug to market...Once Theralase transforms their cancer therapy into an actual commercial drug product available to the world market I'm curious to see what transpires. Obviously the idea of a company buyout sounds amazing for a fair value for a new promising cancer treatment introduced to the world. Maybe a big pharma partnership to further conduct R&D or becoming a drug distributor and producer? 

I would take the buyout offer with the stipulation that whoever knows the rights to this drug/therapy does not shelve it or end its program for self-benefiting developments. 

What is interesting, if this works.....Roger becomes a billionaire. Now, the actual inventor of the drug: Sherri, what's her stake or reward? Was she given stock options or some kind of ownership in TLT? She licensed these PDCs to our company correct? This is her baby....
Bullboard Posts